1. Introduce a sector or industry concerned with the development of a specific product or service. /
2. Describe product or service development in detail. / 3. Cite a specific application. 4. Describe future directions or potential applications of this product or service. /
1. Introduce a sector or industry concerned with the development of a specific product or service. /
Taiwans biotechnology sector has rapidly evolved in line with global trends. Given the increased profits of medical-oriented biotechnology firms, a growing number of seemingly unrelated market sectors have expressed much interest in biotechnology applications. Traditional Chinese medicine is no exception.
Cancer often occurs long before diagnosis, making it difficult to treat and cure. Therapeutic treatment is occasionally so extensive that patients fear it as much as the disease itself.
As the global medical technology has rapidly evolved in recent years, radiation oncology departments have developed new technologies to keep in pace with technological innovations, such as those involving radiation pharmaceuticals and linear accelerators.
2. Describe product or service development in detail. /
Traditional Chinese medicine and other traditional medical treatments have already received considerable attention in the new millennium, as evidenced by the availability of commercial medicinal herb-based products. Having significantly contributed to restoring human health and treating diseases, traditional Chinese medicine and Western medicine differ mainly in drug design and practicality. Preparing traditional Chinese medicine involves complex treatment procedures, in which crude drugs are derived from many chemical compounds and plants constitute more than 80% of the contents.
Positron Emission Tomography (PET) has been extensively adopted in theoretical and clinical experiments for diagnosing cancer in its early stages. For diagnostic purposes, PET acquires physiological images by detecting positrons. Positrons are miniaturized particles emitted from a radioactive substance administered to patients.
With the increasing incidence of cancer in the general population, the health profession has aggressively implemented cancer preventive measures. As the market demand for radiation technology-based cancer treatments increases along with available product innovations, a recent National Science Council report indicated that revenues from the radiation oncology sector ranged from $NT 500 million to 1 billion in Taipei in 2004. Given the large market potential, radiation oncology departments in Taiwanese hospitals have express much interest in radiation oncology technology applications, which have been encouraged by strong governmental support.